Pure Global

Baynex Respiratory Fusion Viral Antigen Rapid Diagnostic Test Card (Unsterilized) - Taiwan Registration 522535a27e2221a7c9955cd0233dde8e

Access comprehensive regulatory information for Baynex Respiratory Fusion Viral Antigen Rapid Diagnostic Test Card (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 522535a27e2221a7c9955cd0233dde8e and manufactured by Abbott Diagnostics Scarborough, Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
522535a27e2221a7c9955cd0233dde8e
Registration Details
Taiwan FDA Registration: 522535a27e2221a7c9955cd0233dde8e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Baynex Respiratory Fusion Viral Antigen Rapid Diagnostic Test Card (Unsterilized)
TW: ๆ‹œๅฅˆๅ…‹ๆ€ๅ‘ผๅธ้“่žๅˆ็—…ๆฏ’ๆŠ—ๅŽŸๅฟซ้€Ÿ่จบๆ–ทๆชข้ฉ—ๅก (ๆœชๆป…่Œ)
Risk Class 1

Registration Details

522535a27e2221a7c9955cd0233dde8e

DHA04401196302

Company Information

United States

Product Details

Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".

C Immunology and microbiology

C.3480 ๅ‘ผๅธ้“่žๅˆ็ดฐ่ƒž็—…ๆฏ’่ก€ๆธ…่ฉฆๅŠ‘

import

Dates and Status

Jul 18, 2012

Jul 18, 2027